NEEDLELESS SYRINGE HAVING MEDICAL AGENT ACCOMMODATED THEREIN
    1.
    发明公开
    NEEDLELESS SYRINGE HAVING MEDICAL AGENT ACCOMMODATED THEREIN 审中-公开
    NADELLOSE SPRITZE MIT DARIN AUFGENOMMENEM MEDIZINISCHEN MITTEL

    公开(公告)号:EP1647292A1

    公开(公告)日:2006-04-19

    申请号:EP04730727.7

    申请日:2004-04-30

    IPC分类号: A61M5/30 C12N15/00

    摘要: The present invention provides a needleless syringe having, accommodated therein, a pharmaceutical preparation containing genes and/or analogues thereof. A needleless syringe comprising: a medical agent chamber 22 having one or multiple nozzle bore(s) 25 and accommodated with a medical agent L, and a syringe main body 12 being provided with pressure application means 32 to apply pressure on the medical agent L toward a direction of the nozzle bore (s) 25 and effect emission of the medical agent L through the nozzle bore (s) 25, wherein the medical agent L is a pharmaceutical preparation containing genes and/or analogues thereof. Examples of the medical agent L include pharmaceutical preparation containing HGF gene and pharmaceutical preparation containing NF-κB decoy oligonucleotide.

    摘要翻译: 本发明提供了一种无针注射器,其中容纳有含有其基因和/或类似物的药物制剂。 一种无针注射器,包括:具有一个或多个喷嘴孔25并容纳有药剂L的药剂处理室22,以及注射器主体12,其设有施加压力的压力施加装置32,以向药剂L施加压力 喷嘴孔25的方向并且通过喷嘴孔25发射药剂L,其中药剂L是含有其基因和/或类似物的药物制剂。 药剂L的实例包括含有HGF基因的药物制剂和含有NF-κB诱饵寡核苷酸的药物制剂。

    ASSAY METHOD OF IDENTIFYING DRUG CANDIDATE
    2.
    发明公开
    ASSAY METHOD OF IDENTIFYING DRUG CANDIDATE 有权
    TESTVERFAHREN ZUR IDENTIFIZIERUNG EINES KANDIDATENARZNEISTOFFS

    公开(公告)号:EP1739425A1

    公开(公告)日:2007-01-03

    申请号:EP05728425.9

    申请日:2005-03-30

    申请人: AnGes MG, Inc.

    IPC分类号: G01N33/50 G01N33/15 G01N33/68

    摘要: The present invention provides a method of identifying a drug candidate capable of removing peptide, oligopeptide, polypeptide or protein from fibril or aggregate, which includes measuring, in the presence of a test compound, the concentration of a soluble peptide, a soluble oligopeptide, a soluble polypeptide or a soluble protein in an equilibrium state in a solvent. Moreover, the present invention provides a dissolution promoter to remove peptide, oligopeptide, polypeptide or protein from fibril or aggregate, which contains the compound obtained by the identification method as an active ingredient.

    摘要翻译: 本发明提供鉴定能够从原纤维或骨料中除去肽,寡肽,多肽或蛋白质的候选药物的方法,其包括在受试化合物存在下测定可溶性肽,可溶性寡肽, 可溶性多肽或溶解在平衡态的可溶性蛋白质。 此外,本发明提供一种溶解促进剂,其从原纤维或聚集体中除去肽,寡肽,多肽或蛋白质,其含有通过鉴定方法获得的化合物作为活性成分。

    GENE THERAPY FOR SKIN DISEASES USING NEEDLE FREE SYRINGE
    4.
    发明公开
    GENE THERAPY FOR SKIN DISEASES USING NEEDLE FREE SYRINGE 审中-公开
    GENTHERAPIEFÜRHAUTERKRANKUNGEN MIT NADELFREIER SPRITZE

    公开(公告)号:EP1671655A1

    公开(公告)日:2006-06-21

    申请号:EP04772726.8

    申请日:2004-08-27

    申请人: AnGes MG, Inc.

    摘要: The present invention provides highly useful clinical methods for treating skin disorders, particularly intractable skin disorders. Specifically, the methods comprise injecting/subcutaneously introducing a 10 µg to 10 mg dose of a polynucleotide, such as a DNA, oligonucleotide, RNA, siRNA, and antisense, around a lesion associated with a skin disorder, such as a wound, cutaneous ulcer, or psoriasis, using a needleless syringe that injects a pharmaceutical liquid by using gas pressure or the elastic force of an elastic member to drive a piston.

    摘要翻译: 本发明提供用于治疗皮肤病症,特别是顽固性皮肤病症的非常有用的临床方法。 具体地说,该方法包括将注射/皮下注射10μg至10mg剂量的多核苷酸,例如DNA,寡核苷酸,RNA,siRNA和反义,在与皮肤病例如伤口,皮肤溃疡相关的病变周围 或银屑病,使用无针注射器,其通过使用气体压力或弹性构件的弹力来驱动活塞而喷射药液。